Objective: There are concerns regarding the potential harms in receipt of prenatal chromosome microarray (CMA) results, particularly variants of uncertain significance (VUS). We examined the influence that the return of genomic results had on parental well-being and perceptions of children's development.
| INTRODUCTION
Molecular cytogenetics has advanced over the last decade and allowed for the detection of copy number variants (CNVs) that were previously unrecognized by conventional cytogenetics. In a previous study, the clinical utility of prenatal chromosome microarray (CMA) testing was evaluated in 4400 individuals undergoing chronic villus sampling (CVS) and amniocentesis for fetal karyotype. In comparison to traditional fetal karyotype, CMA detected additional clinically significant CNVs in 1.7% of the cases, [1] [2] [3] which led the American College of Obstetricians & Gynecologists to recommend that CMA be made available to every woman undergoing prenatal diagnostic testing. 4 During the first 10 years of clinical postnatal use, polymorphic and benign CNVs have been identified and differentiated from pathologic CNVs associated with congenital anomalies, [5] [6] [7] neurological, and psychiatric diseases. [8] [9] [10] [11] [12] [13] [14] [15] [16] Many CNVs were initially classified as variants of uncertain significance (VUS) until large sets of population-based CNV data were available. The delineation of the spectrum of manifestations, frequency, and Preeya Desai and Hannah Haber shared first author role. Catherine Monk and Wendy K. Chung shared senior author role.
severity of symptoms is still incomplete for many rare CNVs, especially regarding manifestations in adults.
The introduction of CMA into prenatal care aims to increase reproductive autonomy by providing clinically relevant genomic information that can enhance parents' decision-making capacity by increasing diagnostic yield and allowing for targeted surveillance of associated clinical features to intervene early and improve outcomes. 8 However,
there are ethical concerns regarding potential harms caused to parents and their infants in receiving ambiguous VUS prenatal results. Although the frequency of CMA VUS will decrease over time, the overall prevalence of VUS CNVs is currently approximately 1%. [17] [18] [19] [20] Furthermore, as the scope of prenatal genomic testing increases and expands to exome/genome sequencing, couples may have the option to receive more genetic information, and a significant fraction could be of uncertain significance, especially for patients of non-European ancestry.
Prospective parents receiving VUS results often do not anticipate the psychological and decision-demanding difficulties associated with uncertainty. 18 Studies have described that upon receiving VUS results, parents report feeling a lack of support, 21 a lack of preparedness, 22 and frustration over the uncertainty and limits in medical knowledge related to VUS. 23 Of particular concern is the potential negative impact on parental psychological well-being and stress 24, 25 that can lead to mood changes, anxiety, and parenting-associated distress. [26] [27] [28] [29] [30] [31] [32] [33] Emerging research suggests that VUS results are associated with parents anxiously monitoring their infants, often enrolling them in early intervention programs or ongoing medical assessments. 33 The VUS results may modify parents' perceptions of their child based on the anticipation of a "damaged" child and could alter the parent-child relationship, potentially contributing to altered behavioral development. While research has been conducted on parental perspectives of the prenatal CMA processes and how receipt of CMA results affects parental stress and anxiety (specifically related to child development), little research has investigated the association between the individual genomic results and parental perceptions of children's behavior, social interaction, and health beyond early infancy. 
| Study overview
Mothers and/or fathers completed questionnaires online at 12 months postpartum, 36 months postpartum, or at both time points (Table 1) .
Twenty children had parent reports from both the mother and father
What's already known about this topic?
• Table 2 for detailed description of each study instrument used.
| Statistical analysis
Unadjusted between-group comparisons (VUS versus normal/LB)
were performed using Wilcoxon's rank-sum test, Kruskal-Wallis, and Three parent trait variables (genetic essentialism, genetic knowledge, and tolerance of ambiguity) were examined as moderators in relation to the 17 parent responses; genetic essentialism was significantly associated with 6 and 13 outcomes at 12 and 36 months, respectively, and considered as an independent variable as well as in interactions with group in models.
| RESULTS
A total of 158 parents of 94 unique children agreed to participate in this study. Table 3 shows enrollment data of children by diagnostic group and sex. Of those who did not agree to participate in this ancillary study, a greater relative proportion received pathogenic prenatal test results. The clinical indication for undergoing the CMA was known from the Wapner study enrollment. As shown in Table 4 , in 55% with pathogenic results, prenatal microarray testing was conducted because of an ultrasound anomaly. In those who received VUS and normal/LB results, the most common reason for prenatal microarray testing was advanced maternal age (42% and 50%, respectively) (Table 4 ). Because parents of only 11 children with pathogenic results agreed to participate in this study, the pathogenic group was not included in analyses. This reduced the number of parents by 20 so that analyses were based on the 138 parents of 83 unique children from the VUS and normal/LB groups.
As represented in Table 5 , the majority of participants were married, white/Caucasian, and not Hispanic/Latino. The average age was 38.1 years. There were no CNV return result group differences in demographic variables (eg, age, marital status, race, ethnicity, education level, offspring sex) (all Ps > .16).
3.1 | Distribution of parent and child outcomes Table 6 shows average values for parent report of child behavior, parenting competence, attachment, perceived child vulnerability, and parent mood at 12 and 36 months. On average, parents rated their children as competent and without many problems and had minimal levels of distress (see Table 2 for details on assessments used).
| Child outcomes by CNV results returned group status
Across 6 surveys of parental perceptions of child development and attachment to the child, there was 1 significant main effect of group status related to outcomes. Compared to the normal/LB group, parents in the VUS group rated their child as less competent on the BITSEA scale at 12 months (β = −1.66, P = .04) though not 36 months (P = .37) (see Figure 1 ). For the BITSEA competence scale, the ofconcern cutoff point is scores <11, indicating the presence of a socioemotional competency delay. A lower score reflects less competence. 34 At 12 months, VUS parents' ratings of their children were at the cutpoint, indicating minimal expected competence (11 on the scale) judged in the clinical range. Data show that health care professionals will refer approximately 7% of these children for further psychosocial evaluation. A 28-item self-report measure assessing the quality of a relationship between a man and woman who are married or living together. Each item is scored on a 4-point Likert scale ranging from 0 to 3 (strongly disagree, disagree, agree, strongly agree). A higher score indicates a more problematic relationship. The GRIMS has good validity and reliability (.90 for women and. 92 for men). 
Secrecy About Results
A 5-item self-report measure of an individual's attitude toward disclosing a health diagnosis. Each question is rated on a 6-point Likert scale from 1 (strongly agree) to 6 (strongly disagree). A higher score corresponds to an endorsement of secrecy. The SAR has good validity, with an alpha of. 71.
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Decision Satisfaction Scale
A 10-item self-report measure assessing levels of satisfaction about a decision. Each item is answered on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). A higher score indicates a more positive attitude toward the decision. 
| Parent trait genetic essentialism
In the group of parents who received VUS results, mothers versus fathers reported significantly higher scores of genetic essentialism (P = .05). Genetic essentialism was not a significant moderator in any outcomes of child development or parent mood (all Ps > .11). ior. 19, 20, 33, 36 Similarly, a recent study investigating parental experience of abnormal fetal ultrasound screenings described that anxiety about the results continued well after the results were proven to be falsepositives, and suggest that genetics is not unique in providing ambiguous prenatal information. 37 Driven by fear of the potential bad outcomes that may be associated with an uncertain genetic result, parents may anxiously overexamine their infant's behavior, finding deficits when there are none. One prior study by Briggs-Gowan et al found that levels of parental worry/anxiety were associated with concerning BITSEA scores on both the social and emotional problem scale and social and emotional competency scale. Most children with worried/anxious parents (62.2%) also had BITSEA scores that fell outside of the normal range. 38 Interestingly, our results showed a lack of differences in self-reported parental mood between parents receiving VUS and normal/LB results. We expected parental mood, specifically parental stress and anxiety from the anticipation of a damaged child, to be significantly different between the normal/LB and the VUS groups. This was not the case, and no measure of parental mood was significantly different between any of the groups which may be because of our use of general versus specific stress scales and may benefit from qualitative interview of the impact of prenatal VUS results on parents.
The significant group difference in parental perception of infant competency observed at 12 months was not present at 36 months, a period when both groups of parents increased their judgment of their child's competence. Consistent with previous studies highlighting parental coping in those who underwent CMA, we suggest that parental perception of infant competency (measured by BITSEA) is less affected by VUS-related vigilance as the infant progresses in development. 33 As additional developmental milestones are reached normally, parents become less anxious, scrutinize their child less, and, therefore, report children as more competent. Despite uncertain genetic results, parents of young children with VUS results remain hopeful about their child's normal development as the child demonstrates typical levels of competence. 39 Similar to another study, which surveyed parents 6 months after the receipt of CMA results, in our study, at 36 months, parents who received VUS results were less satisfied with their decision to undergo CMA testing. 36 We suggest that this dissatisfaction is because of frustration with the current limitations in our ability to interpret genetic results, the influence of ambiguity on parental psychology and parenting styles promoting "watchful waiting," 36 and
parents' increased sense of child competency as the child gets older.
As the child appears more competent, parents may feel regretful of the unnecessary stress and anxiety brought about by the testing process. This experience should be considered as we decide which results to return from prenatal exome and genome sequencing and try to optimize the utility of the test.
| Limitations
Our research study has some limitations. As with a large proportion of genetic studies, our cohort of parents was demographically homogenous. The majority of participants were married or living as married, self-reported as white/Caucasian, and had received at least a college-level education. Future research should investigate parental Chromosome microarray is the first application of large-scale genomic analysis in the prenatal setting. Large-scale analysis will be offered to more as cell-free CMA testing becomes routinely performed on maternal blood. Much more expansive genomic analysis, including large panels, exome, and genome sequencing, will result in parents facing similar challenges of ambiguity, though with much more data, and the challenges may become even more complex.
FIGURE 1
Scores on parent report of child competency through BITSEA. A higher score indicates greater perceived competency.
There is a significant difference in competency scores between VUS and normal/LB parents at 12 months (P = .04), though not 36 months (P = .37). Scores for the normal/LB and VUS groups increased from 12 to 36 months (β = 2.61, P < .0001, and β = 4.12, P < .0001, respectively), but the VUS group's scores increased significantly more (P = .05) [Colour figure can be viewed at wileyonlinelibrary.com]
